PI3K/PTEN/mTOR pathway could have a key role in ACC pathogenesis, as suggested by Ho et al., who determined the ACC mutational landscape identifying recurrent mutations in the FGF-IGF-PI3K pathway (30% of tumors) [64]. The gene discussed is MTOR; the disease is adrenal cortex carcinoma.